Pennant Group (PNTG) | Financial Analysis & Statements
Pennant Group, Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
289.3M
Gross Profit
39.3M
13.57%
Operating Income
17.6M
6.07%
Net Income
10.4M
3.59%
EPS (Diluted)
$0.24
Balance Sheet Metrics
Total Assets
968.2M
Total Liabilities
593.9M
Shareholders Equity
374.3M
Debt to Equity
1.59
Cash Flow Metrics
Operating Cash Flow
10.4M
Free Cash Flow
17.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Pennant Group Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 947.7M | 695.2M | 544.9M | 473.2M | 439.7M |
| Cost of Goods Sold | 817.2M | 601.5M | 477.9M | 414.7M | 391.1M |
| Gross Profit | 130.5M | 93.8M | 67.0M | 58.6M | 48.6M |
| Gross Margin % | 13.8% | 13.5% | 12.3% | 12.4% | 11.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 71.1M | 50.2M | 36.7M | 34.0M | 36.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 71.1M | 50.2M | 36.7M | 34.0M | 36.3M |
| Operating Income | 50.9M | 37.4M | 25.2M | 19.7M | 7.6M |
| Operating Margin % | 5.4% | 5.4% | 4.6% | 4.2% | 1.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 6.7M | 7.0M | 5.9M | 3.8M | 1.9M |
| Other Non-Operating Income | 1.4M | 889.0K | 269.0K | -7.0M | -2.9M |
| Pre-tax Income | 45.6M | 31.4M | 19.6M | 8.9M | 2.7M |
| Income Tax | 11.9M | 7.0M | 5.7M | 1.6M | 582.0K |
| Effective Tax Rate % | 26.0% | 22.4% | 29.0% | 18.5% | 21.3% |
| Net Income | 33.8M | 24.3M | 13.9M | 7.2M | 2.1M |
| Net Margin % | 3.6% | 3.5% | 2.6% | 1.5% | 0.5% |
| Key Metrics | |||||
| EBITDA | 59.8M | 43.8M | 30.7M | 24.6M | 12.3M |
| EPS (Basic) | $0.86 | $0.72 | $0.45 | $0.23 | $0.09 |
| EPS (Diluted) | $0.84 | $0.70 | $0.44 | $0.22 | $0.09 |
| Basic Shares Outstanding | 34563000 | 31191000 | 29863000 | 29064000 | 28406000 |
| Diluted Shares Outstanding | 34563000 | 31191000 | 29863000 | 29064000 | 28406000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Pennant Group Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 17.0M | 24.2M | 6.1M | 2.1M | 5.2M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 123.1M | 81.3M | 61.1M | 53.4M | 53.9M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 27.3M | 17.3M | 12.9M | 18.3M | 16.7M |
| Total Current Assets | 167.4M | 122.9M | 80.1M | 73.8M | 75.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 313.6M | 301.8M | 292.2M | 286.4M | 323.4M |
| Goodwill | 673.9M | 354.4M | 249.8M | 217.6M | 202.3M |
| Intangible Assets | 199.4M | 96.2M | 67.7M | 58.6M | 53.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 27.2M | 17.5M | 9.3M | 12.7M | 8.7M |
| Total Non-Current Assets | 800.8M | 556.7M | 459.6M | 438.3M | 454.5M |
| Total Assets | 968.2M | 679.5M | 539.7M | 512.1M | 530.3M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 25.2M | 18.7M | 10.8M | 13.6M | 10.6M |
| Short-term Debt | 30.0M | 19.7M | 17.1M | 16.6M | 16.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 147.3M | 101.7M | 71.5M | 70.2M | 71.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 423.1M | 253.4M | 312.5M | 309.9M | 339.1M |
| Deferred Tax Liabilities | 150.0K | 1.9M | 1.9M | 0 | - |
| Other Non-Current Liabilities | 23.4M | 10.6M | 8.3M | 6.3M | 5.3M |
| Total Non-Current Liabilities | 446.7M | 265.9M | 322.6M | 316.2M | 344.4M |
| Total Liabilities | 593.9M | 367.6M | 394.2M | 386.5M | 416.1M |
| Equity | |||||
| Common Stock | 35.0K | 35.0K | 29.0K | 29.0K | 28.0K |
| Retained Earnings | 86.8M | 57.2M | 34.7M | 21.3M | 14.6M |
| Treasury Stock | 65.0K | 65.0K | 65.0K | 65.0K | 65.0K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 374.3M | 312.0M | 145.5M | 125.7M | 114.2M |
| Key Metrics | |||||
| Total Debt | 453.2M | 273.1M | 329.6M | 326.6M | 355.2M |
| Working Capital | 20.1M | 21.2M | 8.5M | 3.6M | 4.2M |
Balance Sheet Composition
Pennant Group Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 33.8M | 24.3M | 13.9M | 7.2M | 2.1M |
| Depreciation & Amortization | 8.5M | 6.1M | 5.1M | 4.9M | 4.8M |
| Stock-Based Compensation | 8.9M | 7.8M | 5.4M | 3.1M | 10.0M |
| Working Capital Changes | -16.1M | -12.5M | -8.5M | 2.5M | -9.7M |
| Operating Cash Flow | 33.9M | 25.7M | 20.4M | 19.9M | 6.0M |
| Investing Activities | |||||
| Capital Expenditures | -12.0M | -9.0M | -8.1M | -14.2M | -6.3M |
| Acquisitions | -204.0M | -48.4M | -21.4M | -10.1M | -13.6M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -228.0M | -70.7M | -30.2M | -24.2M | -20.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | 0 | 0 |
| Dividends Paid | - | - | - | - | 0 |
| Debt Issuance | 100.0M | - | - | - | - |
| Debt Repayment | -298.0M | -374.5M | -181.5M | -118.5M | -81.5M |
| Financing Cash Flow | -125.5M | -324.9M | -181.0M | -107.5M | -38.9M |
| Free Cash Flow | 36.3M | 30.3M | 25.0M | -5.1M | -24.5M |
| Net Change in Cash | -319.6M | -369.9M | -190.8M | -111.8M | -53.0M |
Cash Flow Trend
Pennant Group Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.94
Forward P/E
18.71
Price to Book
3.08
Price to Sales
1.07
PEG Ratio
0.74
Profitability Ratios
Profit Margin
3.12%
Operating Margin
6.25%
Return on Equity
9.84%
Return on Assets
3.90%
Financial Health
Current Ratio
1.14
Debt to Equity
122.87
Beta
1.30
Per Share Data
EPS (TTM)
$0.84
Book Value per Share
$9.54
Revenue per Share
$27.42
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PNTG | 1.0B | 34.94 | 3.08 | 9.84% | 3.12% | 122.87 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






